MedPath

Yonsei University

Yonsei University logo
๐Ÿ‡ฐ๐Ÿ‡ทSouth Korea
Ownership
Private
Established
1885-01-01
Employees
5K
Market Cap
-
Website
http://www.yonsei.ac.kr

T-Dxd in Combination With Ramucirumab as HER2 Low Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

Phase 1
Recruiting
Conditions
Gastroesophageal Junction (GEJ) Cancer
Gastric Cancer
Interventions
Drug: T-Dxd(Trastuzmab deruxtecan), Ramucirumab
First Posted Date
2023-06-08
Last Posted Date
2025-01-01
Lead Sponsor
Yonsei University
Target Recruit Count
58
Registration Number
NCT05894824
Locations
๐Ÿ‡ฐ๐Ÿ‡ท

Sun Young Rha, Seoul, ์„œ์šธ, Korea, Republic of

c-MET Inhibitor in Advanced Solid Tumors With c-MET Gene Aberration

Phase 2
Recruiting
Conditions
Neoplasms
Interventions
First Posted Date
2023-05-31
Last Posted Date
2024-12-20
Lead Sponsor
Yonsei University
Target Recruit Count
20
Registration Number
NCT05882292
Locations
๐Ÿ‡ฐ๐Ÿ‡ท

minkyu Jung, Seoul, ์„œ์šธ, Korea, Republic of

Development of Standard References of Maximal Inspiratory Pressure and Maximal Expiratory Pressure in Healthy Adults

Not yet recruiting
Conditions
Healthy Adults
First Posted Date
2023-05-30
Last Posted Date
2023-05-30
Lead Sponsor
Yonsei University
Target Recruit Count
200
Registration Number
NCT05880264
Locations
๐Ÿ‡ฐ๐Ÿ‡ท

Severance hospital, Seoul, Korea, Republic of

Comparison of Patients' Satisfaction Between Dexmedetomidine and Remimazolam Anesthesia in Patients With Atrial Fibrillation Undergoing Catheter Ablation

Not Applicable
Recruiting
Conditions
Patients With Atrial Fibrillation Undergoing Catheter Ablation
Interventions
Drug: remimazolam-remifentanil
Drug: dexmedetomidine-remifentanil
First Posted Date
2023-05-18
Last Posted Date
2023-05-30
Lead Sponsor
Yonsei University
Target Recruit Count
142
Registration Number
NCT05864404
Locations
๐Ÿ‡ฐ๐Ÿ‡ท

Severance hospital, Seoul, Korea, Republic of

Effects of Parental Holding on Pain Response in Young Children During Cystometry

Not Applicable
Completed
Conditions
Filum Terminale Lipoma
Vesico-Ureteral Reflux
Interventions
Behavioral: Holding
Behavioral: Lying
First Posted Date
2023-05-18
Last Posted Date
2023-05-18
Lead Sponsor
Yonsei University
Target Recruit Count
64
Registration Number
NCT05864131
Locations
๐Ÿ‡ฐ๐Ÿ‡ท

College of Nursing and Mo-Im Kim Nursing Research Institute, Yonsei University, Seoul, South Korea, Seoul, Korea, Republic of

Respiratory Rate Validation Study - HiCardi+ Wearable Patch Device, Mezoo Co., Ltd.

Not Applicable
Recruiting
Conditions
Idiopathic Pulmonary Fibrosis
Pulmonary Disease, Chronic Obstructive
Asthma
Interventions
Device: HiCardi+
First Posted Date
2023-05-17
Last Posted Date
2023-05-17
Lead Sponsor
Yonsei University
Target Recruit Count
211
Registration Number
NCT05863091
Locations
๐Ÿ‡ฐ๐Ÿ‡ท

Severance Hospital, Seoul, Korea, Republic of

Effect of Vitis Vinifera Seed Extract on Venous Reflux Time in Varicose Vein

Phase 4
Completed
Conditions
Varicose Veins of Lower Limb
Interventions
Behavioral: Therapeutic lifestyle change only
Drug: Vitis Vinifera seed extract medication plus therapeutic lifestyle change
First Posted Date
2023-05-09
Last Posted Date
2025-03-04
Lead Sponsor
Yonsei University
Target Recruit Count
200
Registration Number
NCT05851183
Locations
๐Ÿ‡ฐ๐Ÿ‡ท

Yongin Severance Hospitall, Yonsei University College of Medicine, Yongin, Gyeonggi-do, Korea, Republic of

A Prediction Model for 1-year Mortality After Valvular Heart Surgery

Recruiting
Conditions
Patients Undergoing Valvular Heart Surgery
First Posted Date
2023-04-27
Last Posted Date
2023-04-27
Lead Sponsor
Yonsei University
Target Recruit Count
2046
Registration Number
NCT05833256
Locations
๐Ÿ‡ฐ๐Ÿ‡ท

Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, Seoul, Korea, Republic of

Effect of Preemptive Low Dose Norepinephrine Infusion on Intraoperative Hemodynamic Stability and Postoperative Outcomes in Patients Undergoing Brain Tumor Resection With a Craniotomy

Not Applicable
Not yet recruiting
Conditions
Brain Tumor
Interventions
First Posted Date
2023-04-18
Last Posted Date
2023-04-18
Lead Sponsor
Yonsei University
Target Recruit Count
70
Registration Number
NCT05814601
Locations
๐Ÿ‡ฐ๐Ÿ‡ท

Yonsei University College of Medicine, Seoul, Korea, Republic of

Study of Induction PD-1 Blockade (Nivolumab) in Patients With Surgically Complete Resectable Mismatch Repair Deficient Endometrial Cancer (NIVEC)

Phase 2
Recruiting
Conditions
Endometrial Cancer
Endometrial Neoplasms
Interventions
First Posted Date
2023-04-03
Last Posted Date
2025-05-13
Lead Sponsor
Yonsei University
Target Recruit Count
30
Registration Number
NCT05795244
Locations
๐Ÿ‡ฐ๐Ÿ‡ท

Severance Hospital, Yonsei University Health System, Seoul, Korea, Republic of

ยฉ Copyright 2025. All Rights Reserved by MedPath